Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Wiedmann

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Heart Rhythm|April 4, 2024
Inhibition of the potassium channel TASK-1 in human atria to reduce arrhythmogenesisPhilipp Hegner, Manuel Schuh, Felix Wiedmann, et al.
International Journal of Molecular Sciences|October 23, 2019
<i>N</i>-Glycosylation of TREK-1/hK<sub>2P</sub>2.1 Two-Pore-Domain Potassium (K<sub>2P</sub>) ChannelsFelix Wiedmann, Daniel Schlund, Francisco Faustino, et al.
Cardiovascular Research|March 1, 2013
Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathyJin Li, Claudia Seyler, Felix Wiedmann, et al.
Frontiers in Pharmacology|April 26, 2021
Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy OptionManuel Kraft, Antonius Büscher, Felix Wiedmann, et al.
Heart Rhythm|November 8, 2024
Comparative evaluation of 2 pulsed field ablation systems for atrial fibrillation: insights from real-world clinical implementation and short-term outcomesMaura M Zylla, Christine Mages, Ann-Kathrin Rahm, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 7, 2013
Functional characterization of zebrafish K2P18.1 (TRESK) two-pore-domain K+ channelsAnn-Kathrin Rahm, Felix Wiedmann, Jakob Gierten, et al.
Journal of Molecular and Cellular Cardiology|October 4, 2023
Activation of neurokinin-III receptors modulates human atrial TASK-1 currentsFelix Wiedmann, Amelie Paasche, Jendrik Nietfeld, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 16, 2024
SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugsFelix Wiedmann, Emika Boondej, Megan Stanifer, et al.
Life Sciences|December 19, 2013
Cardiac expression and atrial fibrillation-associated remodeling of K₂p2.1 (TREK-1) K⁺ channels in a porcine modelConstanze Schmidt, Felix Wiedmann, Frank Tristram, et al.
Clinical Science (London, England : 1979)|March 20, 2016
Therapeutic targeting of two-pore-domain potassium (K(2P)) channels in the cardiovascular systemFelix Wiedmann, Constanze Schmidt, Patrick Lugenbiel, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Heart Rhythm|April 4, 2024
Inhibition of the potassium channel TASK-1 in human atria to reduce arrhythmogenesisPhilipp Hegner, Manuel Schuh, Felix Wiedmann, et al.
International Journal of Molecular Sciences|October 23, 2019
<i>N</i>-Glycosylation of TREK-1/hK<sub>2P</sub>2.1 Two-Pore-Domain Potassium (K<sub>2P</sub>) ChannelsFelix Wiedmann, Daniel Schlund, Francisco Faustino, et al.
Cardiovascular Research|March 1, 2013
Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathyJin Li, Claudia Seyler, Felix Wiedmann, et al.
Frontiers in Pharmacology|April 26, 2021
Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy OptionManuel Kraft, Antonius Büscher, Felix Wiedmann, et al.
Heart Rhythm|November 8, 2024
Comparative evaluation of 2 pulsed field ablation systems for atrial fibrillation: insights from real-world clinical implementation and short-term outcomesMaura M Zylla, Christine Mages, Ann-Kathrin Rahm, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 7, 2013
Functional characterization of zebrafish K2P18.1 (TRESK) two-pore-domain K+ channelsAnn-Kathrin Rahm, Felix Wiedmann, Jakob Gierten, et al.
Journal of Molecular and Cellular Cardiology|October 4, 2023
Activation of neurokinin-III receptors modulates human atrial TASK-1 currentsFelix Wiedmann, Amelie Paasche, Jendrik Nietfeld, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 16, 2024
SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugsFelix Wiedmann, Emika Boondej, Megan Stanifer, et al.
Life Sciences|December 19, 2013
Cardiac expression and atrial fibrillation-associated remodeling of K₂p2.1 (TREK-1) K⁺ channels in a porcine modelConstanze Schmidt, Felix Wiedmann, Frank Tristram, et al.
Clinical Science (London, England : 1979)|March 20, 2016
Therapeutic targeting of two-pore-domain potassium (K(2P)) channels in the cardiovascular systemFelix Wiedmann, Constanze Schmidt, Patrick Lugenbiel, et al.
Pageof 6